You just read:

Avanir Pharmaceuticals Announces Filing of IND for AVP-923 for the Treatment of Central Neuropathic Pain in Patients with Multiple Sclerosis

News provided by

Avanir Pharmaceuticals, Inc.

Apr 04, 2011, 08:30 ET